Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Sweden / NCT06145152
Active, not recruiting Phase 1

Adaptive Training Recommendations for Improved Physical Performance

NCT06145152 · tracked via the Priya Life Science Sweden tracker
Sponsor
The Swedish School of Sport and Health Sciences
Phase
Phase 1
Started
2023-12-05
Last updated
2026-10-08

Condition(s) studied

Maximal Oxygen ConsumptionPhysical Performance

Investigational drug(s) / intervention(s)

Adaptive exercise trainingStatic exercise training

Adaptive exercise training: The training recommendation for the day will be adjusted based on the readiness level. The adjustments can be both up or down (increased or decreased training)

Static exercise training: The training recommendation for the day will not be adjusted based on the readiness level.

Study summary

In this study two different training strategies are compared; one is adaptive where the training is adjusted up or down on a daily basis to better match the recovery status (readiness) of the subject. The other strategy is static, i.e. no changes are made depending on readiness level. Instead the subjects in the static group are encouraged to perform the prescribed training.

The training intervention will last for 8 weeks.

Thorough physiological tests will be performed pre and post the training intervention together with muscle biopsies for assessment of mitochondrial function.

Eligibility

Sex
ALL
Min age
18 Years
Max age
50 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Training history of at least two running sessions per week (5km +) the last 6 months * No chronic diseases * Able to perform maximal exercise * Having used a smart watch for training frequently during the last 3 months * Willing to use wearable technology (Oura ring, continuous glucose monitor, running GPS watch) Exclusion Criteria: * Heart, lung or metabolic disease * Recurrent running injuries * Not willing to use wearable devices * Performing a subtantial amount of non-running exercise training

Primary outcome measure(s)

  • Physical performance — pre intervention and within 5 days post intervention
    3000 meter time trial performance

Trial sites (1)

FacilityCityRegionStatus
Swedish School of Sports and Health Sciences Stockholm Stockholm County

More The Swedish School of Sport and Health Sciences trials in Sweden

Step by Step Back - A Feasibility Study of a Physical Activity Intervention for Adults With Stress-related Exhaustion Recruiting
Timing of Broccoli Sprout Intake to Improve Exercise Performance Recruiting
Training for Men Undergoing Androgen Deprivation Therapy. Recruiting

Other trials for the same condition

Timing of Broccoli Sprout Intake to Improve Exercise Performance Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06145152 on ClinicalTrials.gov ↗ ← All trials in Sweden